MindAhead is a Germany-based startup founded in 2022 with a mission to enable early detection and prevention of cognitive impairments. The company's slogan, "Early detection and treatment of cognitive impairment," encapsulates its core focus. MindAhead operates within the Health Care industry, dedicated to addressing critical health challenges through innovative technology. In January 2023, MindAhead successfully secured a significant €500.00K Pre Seed Round investment, attracting support from a diverse group of investors. These include Moonstone Capital, Ikigai, OHA Osnabrück Healthcare Accelerator, RoX Health, AC75 Startup Accelerator, Rudolf von Plettenberg, CDP Venture Capital, Oskar Obereder, and Cosimo Pulli. This robust backing underscores the confidence in MindAhead's vision and potential for impact. MindAhead's innovative approach to cognitive health aligns with the growing focus on proactive healthcare solutions. The company's ability to attract substantial investment from prominent players in the startup and venture capital landscape reflects the industry's recognition of the pressing need for advancements in cognitive health. MindAhead's future prospects are promising, poised to make meaningful contributions to the evolving health tech sector.
No recent news or press coverage available for MindAhead.